Pfizer doses first participant in phase 3 study evaluating anti-TFPI investigational therapy
Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 24, 2020 at 10:43 AM.
Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 24, 2020 at 10:43 AM.